Trials / Recruiting
RecruitingNCT05117424
CArdioMetabolism and Atherosclerotic PlaqUe progreSsion
The Impact of Cardiometabolic Factors on Coronary Artery and Cardiovascular Diseases: a Prospective Cohort Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Systematic metabolic diseases are closely related to prevalence and progression of atherosclerosis. This prospective cohort consecutively enrolls patients with coronary artery disease compliacted with metabolic abnormalities such as diabtetes, prediabetes, obesity, chronic kidney disease and hyperuricemia.
Detailed description
CArdioMetabolism and Atherosclerotic PlaqUe progreSsion (CAMPUS) study is a single center, prospective cohort study to investigate the impact of cardiometabolic factors on coronary diseases. This study consecutively enrolls patients with coronary artery diseases complicatied with metabolic abnormalities, including diabetes, prediabetes, obesity, chronic kidney disease and hyperuricemia.
Conditions
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2021-11-11
- Last updated
- 2024-08-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05117424. Inclusion in this directory is not an endorsement.